August 14
To download program at a glance of UAA Congress 2025 :
14th August 2025
| Time | Session | ||
|---|---|---|---|
|
08:00
12:00
|
TWTC - 2F Conference Room 5
|
||
|
08:00
10:50
|
TICC - 2F 201BC
|
||
|
08:00
16:50
|
|||
|
08:30
12:00
|
TICC - 1F 101B
|
TICC - 1F 101D
|
Management of UTUC and RIRS Updates
TICC - 1F 102
|
|
09:00
17:30
|
|||
|
09:00
15:00
|
TICC - 1F 101A
|
||
|
10:00
10:30
|
|||
|
12:00
13:00
|
|||
|
13:30
19:00
|
TWTC - 1F Exhibition Hall
|
Oncology Bladder UTUC (A)
TICC - 2F 201BC
|
Oncology Prostate (A)
Pradeep PrakashIndia
Moderator
Single Centre Experience of Robot Assisted Radical Prostatectomy with CMR Versius® Robotic Surgical SystemIntroduction:
Robot assisted radical prostatectomy (RARP) is the standard of care for localized prostate cancer worldwide, but the most important barrier to widespread availability of robotic systems is the associated high cost. Recent availability of newer robotic systems has brought down the cost, but limited data is available about their efficacy and safety.
We present our experience and outcomes of RARP with CMR Versius® surgical system and a comparison of cost-effectiveness to RARP with Da Vinci® surgical system in India.
Materials and Methods:
Consecutive patients undergoing RARP in our department between January 2023 to October 2024 were included. Operative time, docking time of system, anastomosis time, blood loss and other parameters were assessed. Postoperative recovery data and follow up data including days to socially acceptable continence (defined as single diaper use in 24 hours) were recorded.
Results:
Seventeen patients underwent RARP during the study period. The median age was 67 years (Range 58 – 73) and the median BMI was 31.4 (range 26.8 – 39.1). The median prostate size was 48 g (range 28-80) and median PSA was 8.9 ng/dL (4.7 – 18.2). The median operating time was 290 minutes (range 240 – 330) and median vesicourethral anastomosis time was 50 minutes (range 40 – 60). The median docking time was 15 minutes (range 10-25). The median blood loss was 350 ml (250 – 750 ml) and 2 patients (11.7%) required blood transfusion. The robotic malfunction was limited to errors in instruments bedside units which were 5 times in first case which came down to zero by fourth case. There was no major intraoperative or postoperative complications and median hospital stay was 4 days (range 4-6). The median time for return to socially acceptable continence was 10 days (range 3 – 30). The median cost of RARP at our centre was 4470 USD (4117 – 5085 USD) as compared to average 7500 USD for RARP in India with Da Vinci® Surgical system.
Conclusions:
To our knowledge, this is the largest reported series of RARP on CMR Versius® system in India. It is feasible and safe to perform RARP with this system with comparable perioperative and functional recovery outcomes and significant cost benefits compared to Da Vinci® system. The errors encountered during the surgery leads to longer operating times initially but they improve gradually with technical modifications as we get accustomed to the system.
TICC - 1F 102
|
|
13:30
17:00
|
TICC - 1F 101B
|
||
|
15:00
15:30
|
|||
|
15:30
17:00
|
Endourology (A)
Ching-Heng YenTaiwan
Moderator
What are the New Supportive Modalities in the Horizon to Increase the Efficacy of ESWL Extracorporeal shock wave lithotripsy (ESWL) has long been a standard non-invasive modality for managing urinary stones, yet its efficacy remains suboptimal in certain scenarios due to variable stone composition, size, and anatomical factors. Recent advancements have introduced several supportive modalities aimed at enhancing stone fragmentation and clearance. Among these, Burst Wave Lithotripsy (BWL) emerges as a promising technology utilizing focused, low-intensity ultrasound bursts to achieve finer stone fragmentation with greater precision and reduced tissue injury. In parallel, adjunctive approaches such as external physical vibration, ultrasonic propulsion, and optimized patient positioning are gaining traction. Pharmacologic aids including alpha-blockers and potassium citrate have also demonstrated improved stone passage rates post-ESWL. Furthermore, artificial intelligence–driven targeting and real-time imaging advances contribute to improved shock wave focusing and treatment personalization. This review explores the evolving landscape of supportive technologies, with a focus on BWL and its integration with existing ESWL protocols, potentially reshaping the future paradigm of non-invasive stone management.
TICC - 2F 201BC
|
Endourology (A)
Cheng-Chia LinTaiwan
Moderator
DISS plus FANS used in RIRSNew technologies and techniques are constantly emerging, but the most important part of our discussions is how to use them most effectively. Through this surgical demonstration, we hope to share the procedure and our experience with everyone.健保各領域審查共識及討論－結石
TICC - 1F 101A
|
Oncology Bladder UTUC (A)
TICC - 1F 102
|
|
17:00
18:00
|
TICC - 3F Plenary Hall
|
||
|
18:00
20:00
|
TWTC - 1F Exhibition Hall
|
||
|
18:30
20:40
|
Da Vinci SP Experience Sharing Session How Shall We Start?
TICC - 1F 101B
|
||